Article
Co-prescription of Metformin and Antipsychotics in Severe Mental Illness: A UK Primary Care Cohort Study
2024-12-05
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Metformin is a pharmacological candidate to mitigate second-generation antipsychotic (SGA)-induced weight gain in patients with severe mental illnesses (SMI). <h4>Objective</h4> To evaluate the incidence, prevalence, and demographic patterns of metformin co-prescription among patients diagnosed with SMI initiating SGAs. To estimate the impact of co-prescription on weight. <h4>...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4d453e15-9c39-582e-9fce-a050a22d5baa
- DOI
- 10.1101/2024.12.03.24318407
